Search
Search Funnelback University
- Refined by:
- Date: 2022
Your query has been expanded to `news stories` |u:www.enterprize.cam.ac.uk. Search for `news stories` |u:www.enterprise.cam.ac.uk instead.
31 -
40 of
178
search results for `news stories` |u:www.enterprise.cam.ac.uk or `news stories` |u:www.enterprize.cam.ac.uk
Fully-matching results
-
KARPAS 25 Human Myeloma cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-25-human-myeloma-cell-line/9 May 2022: KARPAS 25 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge. -
DIOSynVax: tackling COVID-19 – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/diosynvax-tackling-covid-19/11 Apr 2022: Case study of DIOSynVax, a University of Cambridge spin-out founded by Professor Heeney, which is developing a vaccine for COVID-19. -
Impact Insight: Versed AI – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/impact-insight-versed-ai/12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Versed AI. Share:. Impact Insight video case study: Versed AI. The second in our Impact Insight video series focuses on Versed AI. It tells the story behind the creation -
Develop a commercial opportunity – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/19 Jan 2022: We help University of Cambridge members commercialise their research by transforming their ideas into attractive opportunities. -
KARPAS 417 Human Myeloma cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-417-human-myeloma-cell-line/9 May 2022: KARPAS 417 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge. -
TenU receives £4 million to boost research commercialisation –…
https://www.enterprise.cam.ac.uk/news/tenu-receives-4-million-to-boost-research-commercialisation/18 Aug 2022: International research commercialisation collaboration TenU receives £4m funding boost -
Impact Insight video case study: iKVA – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-ikva/23 Mar 2022: The story behind the creation of iKVA, a University of Cambridge spin-out that uses AI to facilitate knowledge management for multinationals. -
Watch our #nextgreatidea film – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/watch-our-nextgreatidea-film/15 Feb 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Watch our #nextgreatidea film. Share:. Our film is a distinctive take on innovation that showcases some of the world-changing ideas we have supported in the journey to market – from a -
KARPAS 929 Human Myeloma cell line - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/karpas-929-human-myeloma-cell-line/9 May 2022: KARPAS 929 Human Myeloma cell line, developed at the University of Cambridge, useful in oncology research. -
Realising the market potential of software – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/realising-the-market-potential-of-software/18 Jul 2022: Related news and case studies. Pause. Play. Review our answers to your most frequently asked questions.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.